Pharmaceutical
| Sun 10 May 2026
Alexandria, May 11 -- U.S. Patent and Trademark Office has received Kymera Therapeutics patent application for Stat6 Degraders and Uses Thereof. Yang Bin, Follows Bruce C, Dong Huijun, Zhu Xiao, Weiss Matthew M, Zheng Xiaozhang, Huang Xin, Su Lijing, Mainolfi Nello, Beuming Thijs, Fei Xue, Collier Philip and Zhang Yi developed t..